Professional Documents
Culture Documents
ABSTRACT
Submitted: 16/08/2021 COVID-19 causes increasing of inflammatory cytokines even cytokine storm
Accepted : 06/12/2021 in the severe condition. Enhance body immune system is one strategy against
COVID-19. Spices in traditional Indonesian cuisine are believed as boost
Keywords: immunity. They contain active compounds such as curcumin, allicin, quercetin
capsaicin; and capsaicin which can be used to alleviate inflammation. In this literature
COVID-19; review, the potency of curcumin, allicin, quercetin, and capsaicin in alleviating
curcumin; inflammation due the COVID-19 was reported. Literatures were gathered from
allicin; PubMed, Science Direct, and Google Scholar search engines. COVID-19 causes the
quercetin; increase of proinflammatory cytokine levels such as TNFα and IL-6. Curcumin,
allicin, quercetin, and capsaicin regulate the expression of proinflammatory
cytokines. These nutritional agonists of peroxisome proliferator-activated
receptor-γ (PPAR-γ) showed inhibitory effects on pro-inflammatory cytokines
and promote immune cell differentiation into anti-inflammatory phenotypes.
Curcumin has an anti-inflammatory effect that can prevent pneumocytes, renal
cells, and cardiomyocytes damages. Allicin and quercetin can decrease TNFα
and IL-6 levels due to they can increase the superoxide dismutase (SOD) levels.
In conclusion, curcumin, allicin, quercetin and capsaicin can enhance body
immune system due to their anti-inflammatory effect through down-regulation
of the inflammatory cytokines expression. These spices could be used as adjuvant
therapy to boost body immune system against COVID-19.
ABSTRAK
113
Yuliana, The potential effect of natural...
114
IJPTher, Volume 02, Number 3, 2021 September; 112-123
Curcumin
Demethoxycurcumin
Bisdemethoxycurcumin
FIGURE 1. The chemical structure of curcuminoids
isolated from Curcuma longa Linn.17
115
Yuliana, The potential effect of natural...
inhibits the 3C-like protease (3CLpro), were given Sinacurcumin®. The study
interacts with ACE-2 and S proteins.2,16 revealed that Sinacurcumin® could
Curcumin is approved by the US Food reduce the frequency of the Th17 cells.
and Drug Administration (FDA) as a The responses of inflammation were
natural product that has a high potential also reduced in mild to severe COVID-19
for coronaviruses. infected patients. Sinacurcumin®
There are different nanotechnological could be considered as a modulator in
carriers in developing curcumin. improving the patient’s condition during
The nanotechnological carriers are the inflammatory process.21 There
microemulsions, nanoemulsions, was a study to evaluate the curcumin
nanogels, liposomes, micelles, and nanomicelles effectiveness. It also
nanoparticles. During the COVID-19 studies the effects of Sinacurcumin® for
pandemic, there are at least three the COVID-19 treatment. However, there
nanotechnological carriers found for were no studies that had revealed the
curcumin products in the market, namely response of free or entrapped curcumin.
polymeric nanoparticles (Nanocurc™), The antiviral potential against SARS-
nano micelles (Sinacurcumin®), and CoV-2 was not tested either.16
liposomes (Lipocurc™). However, Curcumin is an active molecule for
few studies evaluated the efficacy fighting infection, inflammation, cancer,
of curcumin nanosystem in vivo for and degenerative diseases. However,
COVID-19 infection.16 it is unstable in the cell. Curcumin has
A non-randomized clinical trial improved its bioavailability when it is
to evaluate effectiveness of an oral in nanoformulation. It will enhance
curcumin nanosystem in soft gel capsule its stability and specificity. The stable
preparation (Sinacurcumin®) on mild curcumin molecules are made by
to moderate COVID-19 patients was modifying the methylenic position.
reported. This preparation containing The methylenic position could increase
40 mg of curcuminoids in nanomicelles cellular stability. This special position
was administered two times daily for 14 could remodel the affinity toward DFG-
days. The results of preliminary study in inactive conformation of Hck. Hck
showed that Sinacurcumin® improved has a potential role in cancer and viral
the recovery time of COVID-19 patients infection. Hck regulates cell migration,
faster than without Sinarcurcumin®. differentiation, proliferation, and
Further study was recommended immune receptor signaling. Inhibition
using representative sample size with Hck in COVID-19 patients protected
randomized clinical trial design. against lung injury. It also improved
Another study was conducted pulmonary function.22
to investigate the effects of Curcumin may have a broad-
Sinarcurcumin on the modulation spectrum antiviral activity with
of inflammatory cytokines using a low toxicity. The pharmacological
double-blind randomized clinical mechanism against SARS-CoV2 was
®
trial. The Sinacurcumin (40 mg) was proven through in silico studies.
administered to COVID-19 patients four However, the in vivo antiviral activity
times daily for two weeks and compared of curcumin has not been studied, yet.
with placebo as negative control. Curcumin nanocarriers are available in
Cytokine serum levels and mRNA the market indicated for inflammatory
expression were determined using ELISA agent not for antiviral agent.
and RTPCR, respectively. The resultas Nanosystems and nanoparticles were
showed that expression of IL-1β and IL-6 investigated because of the functional
mRNA was modulated by Sinacurcumin® and possible antiviral synergy. Turmeric
in COVID-19 patients. It may improve (C. longa extract) only contains less than
outcomes and recovery time.3 7% of curcumin concentration. Thus, it
Another study by Tahmasebi et al.21 is not a proper medicine for COVID-19. It
found that there is an anti-inflammatory also lacks FDA approval.16
response in the COVID-19 patients who
116
IJPTher, Volume 02, Number 3, 2021 September; 112-123
Allicin Alliin
E-Ajoene Z-Ajoene
117
Yuliana, The potential effect of natural...
Quercetin Cycloalliin
Alliuocide N-acethylcystein
118
IJPTher, Volume 02, Number 3, 2021 September; 112-123
Red onion extract decreased the quercetin might active against COVID-19
levels of TNF-α, IL-6, and IL-10. Whereas, by reducing the length of SARS-CoV-2
quercetin, one of active compound from infection. Quercetin is might useful
A. cepa L. showed protective effects as prophylactic use. Nevertheless, the
against atherosclerosis in mice. Those preliminary evidence must be confirmed
protective effects are due to reactive by randomized clinical trials to ensure
oxygen species (ROS) suppression. its validity.26
Quercetin modulates the expression
of superoxide dismutase (SOD), H2O2, Capsaicin
malondialdehyde (MDA), and O2.
Quercetin suppressed inflammation Capsaicin is major component of
and apoptosis by regulating the PI3K/ belle pepper (Capsicum annum L.)
AKT and NF-κB pathway, respectively. belonging to Solanaceae family.1,11
Quercetin also decreased IL-6 and TNF-α Capsaicin with other derivatives such as
by increasing SOD levels.26 hidydrocapsaicin, nordihydrocapsaicin,
In silico studies have revealed that homodihydrocapsaicin and
quercetin inhibits the entry of SARS- homocapsaicin have been isolated from
CoV into the host cell by inhibiting the bell pepper (FIGURE 4).
virus main protease (Mpro). Therefore,
Capsaicin
Dihydrocapsaicin Nordihydrocapsaicin
Homodihydrocapsaisin Homocapsaisin
119
Yuliana, The potential effect of natural...
120
IJPTher, Volume 02, Number 3, 2021 September; 112-123
121
Yuliana, The potential effect of natural...
122
IJPTher, Volume 02, Number 3, 2021 September; 112-123
123